1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Urinary Tract Infections
        1.2.3 Surgical Site Infections
        1.2.4 Hospital-acquired Pneumonia
        1.2.5 BloodStream Infections
        1.2.6 Gastrointestinal Infections
    1.3 Market by Application
        1.3.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 ASCs
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Healthcare-associated Infectious Disease Diagnostics Market Perspective (2017-2028)
    2.2 Healthcare-associated Infectious Disease Diagnostics Growth Trends by Region
        2.2.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Region (2017-2022)
        2.2.3 Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028)
    2.3 Healthcare-associated Infectious Disease Diagnostics Market Dynamics
        2.3.1 Healthcare-associated Infectious Disease Diagnostics Industry Trends
        2.3.2 Healthcare-associated Infectious Disease Diagnostics Market Drivers
        2.3.3 Healthcare-associated Infectious Disease Diagnostics Market Challenges
        2.3.4 Healthcare-associated Infectious Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue
        3.1.1 Global Top Healthcare-associated Infectious Disease Diagnostics Players by Revenue (2017-2022)
        3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2017-2022)
    3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Healthcare-associated Infectious Disease Diagnostics Revenue
    3.4 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio
        3.4.1 Global Healthcare-associated Infectious Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
    3.5 Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Area Served
    3.6 Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
    3.7 Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Type
    4.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Type (2017-2022)
    4.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028)
5 Healthcare-associated Infectious Disease Diagnostics Breakdown Data by Application
    5.1 Global Healthcare-associated Infectious Disease Diagnostics Historic Market Size by Application (2017-2022)
    5.2 Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
    6.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        6.2.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
        6.2.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
        6.2.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
    6.3 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        6.3.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
        6.3.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
        6.3.3 North America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
    6.4 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        6.4.1 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
        6.4.2 North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
    7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        7.2.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
        7.2.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
        7.2.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
    7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        7.3.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
        7.3.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
        7.3.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
    7.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        7.4.1 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
        7.4.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
    8.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
    9.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        9.2.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
        9.2.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
        9.2.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
    9.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        9.3.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
        9.3.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
        9.3.3 Latin America Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
    9.4 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        9.4.1 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
        9.4.2 Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size (2017-2028)
    10.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Introduction
        11.1.4 Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.1.5 Abbott Recent Developments
    11.2 Accelerate Diagnostics
        11.2.1 Accelerate Diagnostics Company Details
        11.2.2 Accelerate Diagnostics Business Overview
        11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Introduction
        11.2.4 Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.2.5 Accelerate Diagnostics Recent Developments
    11.3 BD
        11.3.1 BD Company Details
        11.3.2 BD Business Overview
        11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Introduction
        11.3.4 BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.3.5 BD Recent Developments
    11.4 bioMrieux
        11.4.1 bioMrieux Company Details
        11.4.2 bioMrieux Business Overview
        11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Introduction
        11.4.4 bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.4.5 bioMrieux Recent Developments
    11.5 Bio-Rad
        11.5.1 Bio-Rad Company Details
        11.5.2 Bio-Rad Business Overview
        11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Introduction
        11.5.4 Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.5.5 Bio-Rad Recent Developments
    11.6 DiaSorin Molecular
        11.6.1 DiaSorin Molecular Company Details
        11.6.2 DiaSorin Molecular Business Overview
        11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Introduction
        11.6.4 DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.6.5 DiaSorin Molecular Recent Developments
    11.7 F. Hoffmann-La Roche
        11.7.1 F. Hoffmann-La Roche Company Details
        11.7.2 F. Hoffmann-La Roche Business Overview
        11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Introduction
        11.7.4 F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.7.5 F. Hoffmann-La Roche Recent Developments
    11.8 Luminex
        11.8.1 Luminex Company Details
        11.8.2 Luminex Business Overview
        11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Introduction
        11.8.4 Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.8.5 Luminex Recent Developments
    11.9 Meridian Bioscience
        11.9.1 Meridian Bioscience Company Details
        11.9.2 Meridian Bioscience Business Overview
        11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Introduction
        11.9.4 Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.9.5 Meridian Bioscience Recent Developments
    11.10 OpGen
        11.10.1 OpGen Company Details
        11.10.2 OpGen Business Overview
        11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Introduction
        11.10.4 OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.10.5 OpGen Recent Developments
    11.11 QIAGEN
        11.11.1 QIAGEN Company Details
        11.11.2 QIAGEN Business Overview
        11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Introduction
        11.11.4 QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.11.5 QIAGEN Recent Developments
    11.12 Quidel
        11.12.1 Quidel Company Details
        11.12.2 Quidel Business Overview
        11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Introduction
        11.12.4 Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.12.5 Quidel Recent Developments
    11.13 Thermo Fisher Scientific
        11.13.1 Thermo Fisher Scientific Company Details
        11.13.2 Thermo Fisher Scientific Business Overview
        11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Introduction
        11.13.4 Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.13.5 Thermo Fisher Scientific Recent Developments
    11.14 Trinity Biotech
        11.14.1 Trinity Biotech Company Details
        11.14.2 Trinity Biotech Business Overview
        11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Introduction
        11.14.4 Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.14.5 Trinity Biotech Recent Developments
    11.15 Danaher
        11.15.1 Danaher Company Details
        11.15.2 Danaher Business Overview
        11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Introduction
        11.15.4 Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
        11.15.5 Danaher Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Urinary Tract Infections
    Table 3. Key Players of Surgical Site Infections
    Table 4. Key Players of Hospital-acquired Pneumonia
    Table 5. Key Players of BloodStream Infections
    Table 6. Key Players of Gastrointestinal Infections
    Table 7. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2017-2022)
    Table 11. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region (2023-2028)
    Table 13. Healthcare-associated Infectious Disease Diagnostics Market Trends
    Table 14. Healthcare-associated Infectious Disease Diagnostics Market Drivers
    Table 15. Healthcare-associated Infectious Disease Diagnostics Market Challenges
    Table 16. Healthcare-associated Infectious Disease Diagnostics Market Restraints
    Table 17. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Players (2017-2022)
    Table 19. Global Top Healthcare-associated Infectious Disease Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
    Table 20. Ranking of Global Top Healthcare-associated Infectious Disease Diagnostics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Healthcare-associated Infectious Disease Diagnostics Product Solution and Service
    Table 24. Date of Enter into Healthcare-associated Infectious Disease Diagnostics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2017-2022)
    Table 28. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Type (2023-2028)
    Table 30. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2017-2022)
    Table 32. Global Healthcare-associated Infectious Disease Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Healthcare-associated Infectious Disease Diagnostics Revenue Share by Application (2023-2028)
    Table 34. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 35. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 36. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 37. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 38. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 39. North America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 41. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 42. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 43. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 44. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 45. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 50. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & (US$ Million)
    Table 51. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2023-2028) & (US$ Million)
    Table 52. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 53. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 54. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 55. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 56. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 57. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2023-2028) & (US$ Million)
    Table 62. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & (US$ Million)
    Table 63. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2023-2028) & (US$ Million)
    Table 64. Abbott Company Details
    Table 65. Abbott Business Overview
    Table 66. Abbott Healthcare-associated Infectious Disease Diagnostics Product
    Table 67. Abbott Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 68. Abbott Recent Developments
    Table 69. Accelerate Diagnostics Company Details
    Table 70. Accelerate Diagnostics Business Overview
    Table 71. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product
    Table 72. Accelerate Diagnostics Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 73. Accelerate Diagnostics Recent Developments
    Table 74. BD Company Details
    Table 75. BD Business Overview
    Table 76. BD Healthcare-associated Infectious Disease Diagnostics Product
    Table 77. BD Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 78. BD Recent Developments
    Table 79. bioMrieux Company Details
    Table 80. bioMrieux Business Overview
    Table 81. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product
    Table 82. bioMrieux Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 83. bioMrieux Recent Developments
    Table 84. Bio-Rad Company Details
    Table 85. Bio-Rad Business Overview
    Table 86. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product
    Table 87. Bio-Rad Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 88. Bio-Rad Recent Developments
    Table 89. DiaSorin Molecular Company Details
    Table 90. DiaSorin Molecular Business Overview
    Table 91. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product
    Table 92. DiaSorin Molecular Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 93. DiaSorin Molecular Recent Developments
    Table 94. F. Hoffmann-La Roche Company Details
    Table 95. F. Hoffmann-La Roche Business Overview
    Table 96. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product
    Table 97. F. Hoffmann-La Roche Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 98. F. Hoffmann-La Roche Recent Developments
    Table 99. Luminex Company Details
    Table 100. Luminex Business Overview
    Table 101. Luminex Healthcare-associated Infectious Disease Diagnostics Product
    Table 102. Luminex Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 103. Luminex Recent Developments
    Table 104. Meridian Bioscience Company Details
    Table 105. Meridian Bioscience Business Overview
    Table 106. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product
    Table 107. Meridian Bioscience Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 108. Meridian Bioscience Recent Developments
    Table 109. OpGen Company Details
    Table 110. OpGen Business Overview
    Table 111. OpGen Healthcare-associated Infectious Disease Diagnostics Product
    Table 112. OpGen Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 113. OpGen Recent Developments
    Table 114. QIAGEN Company Details
    Table 115. QIAGEN Business Overview
    Table 116. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product
    Table 117. QIAGEN Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 118. QIAGEN Recent Developments
    Table 119. Quidel Company Details
    Table 120. Quidel Business Overview
    Table 121. Quidel Healthcare-associated Infectious Disease Diagnostics Product
    Table 122. Quidel Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 123. Quidel Recent Developments
    Table 124. Thermo Fisher Scientific Company Details
    Table 125. Thermo Fisher Scientific Business Overview
    Table 126. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product
    Table 127. Thermo Fisher Scientific Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 128. Thermo Fisher Scientific Recent Developments
    Table 129. Trinity Biotech Company Details
    Table 130. Trinity Biotech Business Overview
    Table 131. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product
    Table 132. Trinity Biotech Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 133. Trinity Biotech Recent Developments
    Table 134. Danaher Company Details
    Table 135. Danaher Business Overview
    Table 136. Danaher Healthcare-associated Infectious Disease Diagnostics Product
    Table 137. Danaher Revenue in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022) & (US$ Million)
    Table 138. Danaher Recent Developments
    Table 139. Research Programs/Design for This Report
    Table 140. Key Data Information from Secondary Sources
    Table 141. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Type: 2021 VS 2028
    Figure 2. Urinary Tract Infections Features
    Figure 3. Surgical Site Infections Features
    Figure 4. Hospital-acquired Pneumonia Features
    Figure 5. BloodStream Infections Features
    Figure 6. Gastrointestinal Infections Features
    Figure 7. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Application: 2021 VS 2028
    Figure 8. Hospitals Case Studies
    Figure 9. Clinics Case Studies
    Figure 10. ASCs Case Studies
    Figure 11. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
    Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Region: 2021 VS 2028
    Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Share by Players in 2021
    Figure 16. Global Top Healthcare-associated Infectious Disease Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-associated Infectious Disease Diagnostics as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Healthcare-associated Infectious Disease Diagnostics Revenue in 2021
    Figure 18. North America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 19. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 20. North America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 21. North America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 22. United States Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 25. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 26. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 27. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 28. Germany Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. France Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. U.K. Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Italy Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Russia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Nordic Countries Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 35. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 36. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 37. Asia Pacific Healthcare-associated Infectious Disease Diagnostics Market Size Share by Region (2017-2028)
    Figure 38. China Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Japan Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. South Korea Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. India Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Australia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 44. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 45. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 46. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 47. Latin America Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 48. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size YoY (2017-2028) & (US$ Million)
    Figure 51. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2028)
    Figure 52. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2028)
    Figure 53. Middle East and Africa Healthcare-associated Infectious Disease Diagnostics Market Size Share by Country (2017-2028)
    Figure 54. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. UAE Healthcare-associated Infectious Disease Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Abbott Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 58. Accelerate Diagnostics Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 59. BD Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 60. bioMrieux Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 61. Bio-Rad Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 62. DiaSorin Molecular Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 64. Luminex Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 65. Meridian Bioscience Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 66. OpGen Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 67. QIAGEN Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 68. Quidel Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 69. Thermo Fisher Scientific Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 70. Trinity Biotech Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 71. Danaher Revenue Growth Rate in Healthcare-associated Infectious Disease Diagnostics Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed